Researchers discovered a 60% higher risk of suffering a first heart attack, stroke, or cardiac dysrhythmia if the patient deals with cannabis use disorder.
While alcohol impairment is closely linked to blood alcohol concentrations, the same doesn't apply to tetrahydrocannabinol (THC) levels in the bloodstream.
AEFO117 significantly reduced the effects of using marijuana among daily smokers and offers a safe and effective treatment option for individuals struggling with cannabis use disorder.